211 related articles for article (PubMed ID: 7985331)
1. Role of multidrug resistance in tumors of the genitourinary tract.
Theyer G; Hamilton G
Urology; 1994 Dec; 44(6):942-50. PubMed ID: 7985331
[No Abstract] [Full Text] [Related]
2. Genitourinary cancer.
Hudes GR; Ozols RF; Schilder RJ
Cancer Chemother Biol Response Modif; 1991; 12():509-48. PubMed ID: 1718377
[No Abstract] [Full Text] [Related]
3. Circumvention of multidrug resistance in genitourinary tumors.
van Brussel JP; Mickisch GH
Int J Urol; 1998 Jan; 5(1):1-15. PubMed ID: 9535594
[TBL] [Abstract][Full Text] [Related]
4. A review of therapeutic strategies for phase I-II trials in genitourinary cancer.
Friedman MA
Recent Results Cancer Res; 1980; 70():203-10. PubMed ID: 7188814
[No Abstract] [Full Text] [Related]
5. [A new anti-cancer agent, bestrabucil (KM 2210): I. Concentration in the serum and tissue in urogenital tumors].
Nasu Y; Saegusa M; Hara M; Ochi J; Akagi T; Obama T; Tsushima T; Yoshimoto J; Ozaki Y; Matsumura Y
Gan To Kagaku Ryoho; 1987 Apr; 14(4):1116-21. PubMed ID: 3566306
[TBL] [Abstract][Full Text] [Related]
6. Treatment of genitourinary tumours with cis-dichlorodiammineplatinum(II): experience in 250 patients.
Merrin CE
Cancer Treat Rep; 1979; 63(9-10):1579-84. PubMed ID: 574057
[No Abstract] [Full Text] [Related]
7. The role of chemotherapy in the management of malignant urogenital neoplasms.
Schnipper LE
Urol Clin North Am; 1976 Jun; 3(2):423-32. PubMed ID: 960317
[No Abstract] [Full Text] [Related]
8. Genitourinary cancer.
Ozols RF; Yagoda A
Cancer Chemother Biol Response Modif; 1988; 10():271-90. PubMed ID: 2856330
[No Abstract] [Full Text] [Related]
9. Genitourinary malignancies.
Smith MR; Kantoff P
Cancer Chemother Biol Response Modif; 1999; 18():394-417. PubMed ID: 10800495
[No Abstract] [Full Text] [Related]
10. [Guideline for proper use of antineoplastic agents. Urologic cancer].
Akaza H; Miyanaga N
Gan To Kagaku Ryoho; 2002 Jun; 29(6):1055-64. PubMed ID: 12109446
[No Abstract] [Full Text] [Related]
11. Chemotherapy of genitourinary malignancies.
Gordon RL
Semin Drug Treat; 1973; 3(1):69-72. PubMed ID: 4123696
[No Abstract] [Full Text] [Related]
12. [Chemotherapy of urogenital cancers].
Matsumura Y; Tsushima T
Nihon Hinyokika Gakkai Zasshi; 1991 Feb; 82(2):181-9. PubMed ID: 2041265
[No Abstract] [Full Text] [Related]
13. Genitourinary malignancies.
Michaelson MD; Smith MR
Cancer Chemother Biol Response Modif; 2003; 21():547-64. PubMed ID: 15338763
[No Abstract] [Full Text] [Related]
14. Biennial report on genitourinary cancers.
Fizazi K
Eur J Cancer; 2016 Oct; 66():125-30. PubMed ID: 27569040
[TBL] [Abstract][Full Text] [Related]
15. Chemotherapy of urogenital cancer.
Merrin CE; Murphy GP
Surg Annu; 1976; 8():391-412. PubMed ID: 180617
[No Abstract] [Full Text] [Related]
16. Optimizing utilization of targeted therapies in genitourinary cancers.
Bukowski RM
Clin Genitourin Cancer; 2008 Dec; 6 Suppl 1():S6. PubMed ID: 19891123
[No Abstract] [Full Text] [Related]
17. Cancer chemotherapy in urology.
Furnari S; Pavone-Macaluso M; Veroux G; Mattea E
Urol Int; 1971; 26(4):315-20. PubMed ID: 4331514
[No Abstract] [Full Text] [Related]
18. Targeting the endothelin system: novel therapeutic options in gynecological, urological and breast cancers.
Smollich M; Wülfing P
Expert Rev Anticancer Ther; 2008 Sep; 8(9):1481-93. PubMed ID: 18759699
[TBL] [Abstract][Full Text] [Related]
19. [Cytostatic adjuvant therapy of tumors in the urogenital region].
Vahlensieck W
Haematol Blood Transfus; 1978; 22():165-74. PubMed ID: 220154
[No Abstract] [Full Text] [Related]
20. Future directions for gemcitabine in the treatment of genitourinary cancer.
Vogelzang NJ
Semin Oncol; 2002 Feb; 29(1 Suppl 3):40-5. PubMed ID: 11894007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
